October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
October 31, 2013
October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education ...
October 28, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside ...
October 25, 2013
October 14, 2013 — Since its debut in 2010, the renal denervation market has generated enthusiasm across the medical ...
October 14, 2013
September 27, 2013 — Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center ...
September 27, 2013September 9, 2013 -- Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme ...
September 09, 2013
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal ...
September 03, 2013
August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology department ...
August 22, 2013
August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S ...
August 02, 2013
Feature | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat ...
July 30, 2013
Feature | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented ...
July 03, 2013June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN ...
June 13, 2013
June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN clinical program, which ...
June 06, 2013
June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...
June 03, 2013May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study evaluating ...
May 30, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now